ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $3.77 billion. The enterprise value is $3.07 billion.
| Market Cap | 3.77B |
| Enterprise Value | 3.07B |
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 168.71 million shares outstanding. The number of shares has increased by 1.10% in one year.
| Current Share Class | 168.71M |
| Shares Outstanding | 168.71M |
| Shares Change (YoY) | +1.10% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 70.47% |
| Float | 115.87M |
Valuation Ratios
The trailing PE ratio is 16.87 and the forward PE ratio is 36.44. ACAD's PEG ratio is 7.48.
| PE Ratio | 16.87 |
| Forward PE | 36.44 |
| PS Ratio | 3.66 |
| Forward PS | 3.28 |
| PB Ratio | 4.59 |
| P/TBV Ratio | 5.33 |
| P/FCF Ratio | 20.17 |
| P/OCF Ratio | 20.09 |
| PEG Ratio | 7.48 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.51, with an EV/FCF ratio of 16.40.
| EV / Earnings | 13.81 |
| EV / Sales | 3.01 |
| EV / EBITDA | 29.51 |
| EV / EBIT | 33.98 |
| EV / FCF | 16.40 |
Financial Position
The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.91 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | 0.30 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 33.18% and return on invested capital (ROIC) is 7.77%.
| Return on Equity (ROE) | 33.18% |
| Return on Assets (ROA) | 5.28% |
| Return on Invested Capital (ROIC) | 7.77% |
| Return on Capital Employed (ROCE) | 10.08% |
| Revenue Per Employee | $1.56M |
| Profits Per Employee | $339,694 |
| Employee Count | 654 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 8.30 |
Taxes
In the past 12 months, ACAD has paid $45.72 million in taxes.
| Income Tax | 45.72M |
| Effective Tax Rate | 17.07% |
Stock Price Statistics
The stock price has increased by +51.05% in the last 52 weeks. The beta is 0.75, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +51.05% |
| 50-Day Moving Average | 22.93 |
| 200-Day Moving Average | 20.48 |
| Relative Strength Index (RSI) | 52.81 |
| Average Volume (20 Days) | 1,970,675 |
Short Selling Information
The latest short interest is 8.75 million, so 5.19% of the outstanding shares have been sold short.
| Short Interest | 8.75M |
| Short Previous Month | 9.41M |
| Short % of Shares Out | 5.19% |
| Short % of Float | 7.55% |
| Short Ratio (days to cover) | 3.55 |
Income Statement
In the last 12 months, ACAD had revenue of $1.02 billion and earned $222.16 million in profits. Earnings per share was $1.33.
| Revenue | 1.02B |
| Gross Profit | 613.55M |
| Operating Income | 90.30M |
| Pretax Income | 267.88M |
| Net Income | 222.16M |
| EBITDA | 103.97M |
| EBIT | 90.30M |
| Earnings Per Share (EPS) | $1.33 |
Balance Sheet
The company has $762.00 million in cash and $56.29 million in debt, giving a net cash position of $705.70 million or $4.18 per share.
| Cash & Cash Equivalents | 762.00M |
| Total Debt | 56.29M |
| Net Cash | 705.70M |
| Net Cash Per Share | $4.18 |
| Equity (Book Value) | 822.38M |
| Book Value Per Share | 4.88 |
| Working Capital | 630.53M |
Cash Flow
In the last 12 months, operating cash flow was $187.91 million and capital expenditures -$820,000, giving a free cash flow of $187.09 million.
| Operating Cash Flow | 187.91M |
| Capital Expenditures | -820,000 |
| Free Cash Flow | 187.09M |
| FCF Per Share | $1.11 |
Margins
Gross margin is 60.22%, with operating and profit margins of 8.86% and 21.80%.
| Gross Margin | 60.22% |
| Operating Margin | 8.86% |
| Pretax Margin | 26.29% |
| Profit Margin | 21.80% |
| EBITDA Margin | 10.20% |
| EBIT Margin | 8.86% |
| FCF Margin | 18.36% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.10% |
| Shareholder Yield | -1.10% |
| Earnings Yield | 5.89% |
| FCF Yield | 4.96% |
Analyst Forecast
The average price target for ACAD is $29.43, which is 31.56% higher than the current price. The consensus rating is "Buy".
| Price Target | $29.43 |
| Price Target Difference | 31.56% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 11.57% |
| EPS Growth Forecast (5Y) | 14.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 3.53 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.53 |
| Piotroski F-Score | 5 |